Maravai LifeSciences Reports Fourth Quarter and Full Year 2021 Financial Results and Updates 2022 Financial GuidanceGlobeNewsWire • 02/23/22
Maravai LifeSciences Acquires MyChem, a Leader in Proprietary Ultra-Pure NucleotidesGlobeNewsWire • 01/28/22
Maravai LifeSciences Announces Registration and Webcast Information for Upcoming R&D Day, to be Held on January 28, 2022GlobeNewsWire • 01/05/22
Is Maravai LifeSciences Holdings, Inc. (MRVI) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 12/28/21
Earnings Estimates Moving Higher for Maravai LifeSciences Holdings, Inc. (MRVI): Time to Buy?Zacks Investment Research • 12/06/21
Can Maravai LifeSciences Holdings, Inc. (MRVI) Climb 25% to Reach the Level Wall Street Analysts Expect?Zacks Investment Research • 12/06/21
How Much Upside is Left in Maravai LifeSciences (MRVI)? Wall Street Analysts Think 40%Zacks Investment Research • 11/15/21
Maravai LifeSciences Holdings, Inc. (MRVI) CEO Carl Hull on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/11/21
Maravai LifeSciences Reports Third Quarter Financial Results, Updates 2021 Financial Guidance and Provides Preliminary Revenue Guidance For 2022GlobeNewsWire • 11/10/21
New England Biolabs® releases next generation HiScribe™ in vitro transcription kit, incorporating TriLink® Biotechnologies' CleanCap® technology for mRNA synthesisPRNewsWire • 11/08/21
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 10, 2021GlobeNewsWire • 10/13/21
Maravai LifeSciences Expands its Intellectual Property Portfolio with European PatentGlobeNewsWire • 10/07/21
TriLink BioTechnologies® Extends EyeGene Partnership for COVID-19 Vaccine Development in South KoreaGlobeNewsWire • 10/04/21
Maravai LifeSciences Announces Pricing of Secondary Offering of Class A Common Stock by Selling StockholdersGlobeNewsWire • 09/10/21
Maravai LifeSciences Announces Launch of Proposed Secondary Offering of Class A Common Stock by Selling StockholdersGlobeNewsWire • 09/07/21